EMA Headquarters to Move to Amsterdam
The European Medicines Agency (EMA), the EU body responsible for the evaluation of medicinal products for use within the European Union, concluded a vote on Monday evening in Brussels following…
Netherlands
Global / Access to Medicines Index 2022: Big Pharma Steps Up Access Efforts with GSK Top Again
The Access to Medicine Index, a biennial report that gauges the efforts of the world’s largest pharma companies to expand access in low- and middle-income countries (LMICs), found in this year’s edition that the 20 companies surveyed have firmly responded…
The Netherlands: A Fertile Garden for Innovation
Despite lacking a national champion to bolster its innovative eco-system since the 2007 acquisition of Organon by Schering Plough, the Netherlands nevertheless still sits in fourth position on the 2015…
Netherlands / Argenx to Go it Alone; Agendia Backs Out of IPO; Pleco AML Financing
The latest news from the Dutch pharma, biotech and healthcare industries, including the bullish comments of Argenx CEO Tim Van Hauwermeiren following the successful launch of its Vyvgart product; cancer…